US Broker Ratings

National Research Corporation (NRC) Stock Analysis: Balancing Robust ROE and Dividend Yield Amidst Revenue Challenges

National Research Corporation (NRC), trading on the U.S. exchange in the healthcare sector, specializes in health information services, providing an essential suite of analytics and insights for healthcare organizations. With..

Health Catalyst, Inc (HCAT) Stock Analysis: Potential Upside of 116% Piques Investor Interest

For investors navigating the healthcare sector, Health Catalyst, Inc. (NASDAQ: HCAT) offers an intriguing opportunity with its robust data and analytics technology services for healthcare organizations. Based in South Jordan,..

Nyxoah SA (NYXH) Stock Analysis: Exploring a 149% Potential Upside in the Healthcare Sector

Nyxoah SA (NYSE: NYXH), a Belgium-based healthcare company specializing in medical instruments and supplies, is capturing investor attention with a notable potential upside of 149.14%. As the developer of the..

aTyr Pharma (ATYR) Stock Analysis: Exploring a Potential 327% Upside in the Biotech Sector

Investors with a penchant for high-risk, high-reward opportunities in the biotechnology sector may find aTyr Pharma, Inc. (NASDAQ: ATYR) an intriguing prospect. With a market capitalization of $99.95 million, this..

Canopy Growth Corporation (CGC): Investor Outlook with a 53% Potential Upside

Canopy Growth Corporation (NYSE: CGC), a major player in the cannabis industry, has been capturing investor interest amid a challenging market environment. As a Canadian firm deeply involved in the..

Quantum-Si Incorporated (QSI) Stock Analysis: Exploring a Potential 171% Upside in the Healthcare Sector

Quantum-Si Incorporated (NASDAQ: QSI), a promising player in the healthcare sector, specifically within the medical devices industry, is making waves with its innovative approach to Next Generation Protein Sequencing (NGPS)...

TruBridge, Inc. (TBRG) Stock Analysis: Exploring a Potential 12.6% Upside in Healthcare IT

As the healthcare industry continues to evolve with technological advancements, TruBridge, Inc. (NASDAQ: TBRG) stands out as a pivotal player in the health information services sector. Specializing in revenue cycle..

Arcturus Therapeutics (ARCT) Stock Analysis: Exploring a 304% Potential Upside Amidst Clinical Pipeline Advances

Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT) stands at an intriguing crossroads, capturing the attention of investors with its promising biotechnology initiatives and a staggering 304.28% potential upside. This San Diego-based..

TotalEnergies SE (TTE) Investor Outlook: Navigating a Potential -4.23% Downside with Strong Dividends

As one of the leading integrated energy companies globally, TotalEnergies SE (TTE) presents a nuanced investment case for those interested in the energy sector. Based in Courbevoie, France, this multinational..

Fulcrum Therapeutics, Inc. (FULC): Analyst Ratings Suggest 111% Upside Potential – Is It Time to Buy?

Fulcrum Therapeutics, Inc. (NASDAQ: FULC) is a name that has been garnering attention in the healthcare sector, particularly within the biotechnology industry. Based in Cambridge, Massachusetts, Fulcrum is a clinical-stage..

ClearPoint Neuro Inc. (CLPT) Stock Analysis: Uncovering a Potential 91% Upside in the Medical Device Sector

ClearPoint Neuro Inc. (NASDAQ: CLPT), a trailblazer in the healthcare sector, specifically within the medical devices industry, stands out with its innovative solutions for minimally invasive brain surgeries. Headquartered in..

Exxon Mobil (XOM) Stock Analysis: Navigating Market Challenges with Strategic Insights

Exxon Mobil Corporation (NYSE: XOM), a titan in the energy sector, continues to be a focal point for investors with its robust market presence and strategic ventures. With a market..

Absci Corporation (ABSI): Investor Outlook on a Biotech with Nearly 194% Potential Upside

Absci Corporation (NASDAQ: ABSI), a trailblazing entity in the biotechnology industry, is capturing investor attention with its unique approach to drug creation using generative artificial intelligence (AI). Based in Vancouver,..

Opko Health, Inc. (OPK) Stock Analysis: A Closer Look at Its 209% Potential Upside

Opko Health, Inc. (NASDAQ: OPK), a key player in the healthcare sector focusing on diagnostics and pharmaceuticals, has captured investor attention with an intriguing potential upside of 209.42%. This significant..

Aurinia Pharmaceuticals (AUPH) Stock Analysis: A Look at Its 12.38% Potential Upside

Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) is capturing investor attention with its notable position in the biotechnology sector, poised with a potential upside of 12.38%. As a key player in the..

agilon health, inc. (AGL) Stock Analysis: Unpacking a 127% Potential Upside Amidst Market Challenges

agilon health, inc. (AGL) is a compelling entity within the healthcare sector, specifically in the medical care facilities industry. Based in Westerville, Ohio, agilon health aims to revolutionize senior healthcare..

Novavax, Inc. (NVAX) Growth Potential: Analyst Ratings Highlight a 37.70% Upside

Novavax, Inc. (NASDAQ: NVAX), a prominent player in the biotechnology sector, has captured the attention of both investors and industry analysts with its innovative approach to vaccine development. With a..

BioLife Solutions, Inc. (BLFS) Stock Analysis: Unpacking the 41.80% Potential Upside

For investors eyeing the healthcare sector, BioLife Solutions, Inc. (NASDAQ: BLFS) presents a compelling opportunity, particularly with analysts projecting a potential upside of 41.80%. This Bothell, Washington-based company specializes in..

MiMedx Group, Inc (MDXG) Stock Analysis: Exploring an 81% Potential Upside in the Biotech Sector

Investors with an appetite for growth in the biotechnology sector may want to take a closer look at MiMedx Group, Inc. (NASDAQ: MDXG), a company that stands out with an..

Wave Life Sciences Ltd. (WVE) Stock Analysis: Exploring 147% Upside in Biotech Innovation

Wave Life Sciences Ltd. (NASDAQ: WVE), a Singapore-based biotechnology company, has captured investor attention with a remarkable potential upside of 147.22%. Specializing in RNA medicine, Wave Life Sciences leverages its..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds